Showing results (31-40 of 37) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 11, 2003
A novel, non-prostanoid EP2 receptor-selective prostaglandin E2 agonist stimulates local bone formation and enhances fracture healingMei Li, Hua Zhu Ke, Hong Qi, et al.The Journal of Biological Chemistry|November 8, 2002
Targeted disruption of the osteoblast/osteocyte factor 45 gene (OF45) results in increased bone formation and bone massLori C Gowen, Donna N Petersen, Amy L Mansolf, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Metabolism-guided design of short-acting calcium-sensing receptor antagonistsJames A Southers, Jonathan N Bauman, David A Price, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 7, 2006
A nonprostanoid EP4 receptor selective prostaglandin E2 agonist restores bone mass and strength in aged, ovariectomized ratsHua Zhu Ke, D Todd Crawford, Hong Qi, et al.Bioorganic & Medicinal Chemistry Letters|May 6, 2004
Tetrahydroisoquinolines as subtype selective estrogen agonists/antagonistsRichard Chesworth, Michael P Zawistoski, Bruce A Lefker, et al.Bioorganic & Medicinal Chemistry Letters|October 13, 2005
Estrogen receptor beta selective ligands: discovery and SAR of novel heterocyclic ligandsRichard Chesworth, Matthew D Wessel, Lisa Heyden, et al.Proceedings of the National Academy of Sciences of the United States of America|June 1, 2007
Proline-rich tyrosine kinase 2 regulates osteoprogenitor cells and bone formation, and offers an anabolic treatment approach for osteoporosisLeonard Buckbinder, David T Crawford, Hong Qi, et al.Pageof 4